Symptomatic Hypercalcemia in Patients with Primary Hyperparathyroidism Is Associated with Severity of Disease, Polypharmacy, and Comorbidity

<div>Differences in multimorbidity and polypharmacy between HS-PHPT and A-PHPT. Median values of age-adjusted Charlson index (a) and of the number of medications (b) differed between HS-PHPT and A-PHPT patients. Data are presented as median and range interquartile by box, and wisker plots represent minimum and maximum values. Statistical significance was determined by the Mann–Whitney test. HS-PHPT, hypercalcemic-related symptomatic PHPT (black circles); A-PHPT, asymptomatic PHPT (grey squares).</div>

International Journal of Endocrinology

fig2

Figure 2

Figure 2: Symptomatic Hypercalcemia in Patients with Primary Hyperparathyroidism Is Associated with Severity of Disease, Polypharmacy, and Comorbidity 

Figure 2 | Symptomatic Hypercalcemia in Patients with Primary Hyperparathyroidism Is Associated with Severity of Disease, Polypharmacy, and Comorbidity 